There is no quality control unit.
Inspection Record
Regen Suppliers LLC — FDA 483 Findings
Inspectors Garrad R Poole · Laurissa S Flowers · Emily S McgannThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
A system by which the distribution of each lot of drug product can be readily determined to facilitate its recall if necessary, has not been established.
After the completion of the donor-eligibility determination, HCT/Ps were not accompanied with a statement whether the donor has been determined to be eligible or ineligible, based on the results of screening and testing.
Procedures describing the handling of all written and oral complaints regarding a drug product are not established.
Drug product expiration dates do not appear on the labeling in the manner prescribed by regulations.
The distribution system is deficient in that each lot of drug product cannot be readily determined to facilitate its recall if necessary.
Procedures designed to assure that correct labeling and packaging materials are used for drug products are not written.
Complaint procedures are deficient in that written complaint records are not maintained in a file designated for drug product complaints.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Bello Bio LLC2025-12-16 · US FDASimilar to finding 1 There is no quality control unit.
- SURETEC INNOVATIONS LLC2026-03-05 · US FDASimilar to finding 1 There is no quality control unit.
- Clarcon Biological Chemistry Laboratory2015-07-24 · US FDASimilar to finding 1 There is no quality control unit.
- McNeil Consumer Healthcare2015-07-23 · US FDASimilar to finding 4 Procedures describing the handling of all written and oral complaints regarding a drug product are not followed.
- New England Life Care, Inc., dba Advanced Compounding Solutions2017-09-29 · US FDASimilar to finding 4 Procedures describing the handling of all written and oral complaints regarding a drug product are not written.
A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.